Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients
about
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical modelsComparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumorsFrom mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC).Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.The tuberous sclerosis complex genes in tumor development.Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences.Cortical dysplasia: a possible substrate for brain tumors.Genetics and molecular biology of tuberous sclerosis complex.Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.Association of cytokine/costimulatory molecule polymorphism and allograft rejection: a comparative review.Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups.A differential association of interferon-gamma high-producing allele T and low-producing allele A (+874 A/T) with Hashimoto's thyroiditis and Graves' disease.
P2860
Q33305157-B9AEB486-8FE7-4FE2-B36F-CA3C19E7217EQ33430534-FAA1ADE3-3399-4359-AE23-020C8F40552FQ33711691-E3BC59FC-53A8-4FB4-9E26-DBA77AF1446CQ33750454-230671E0-552F-47C2-8C74-472B6FD9B582Q33905094-29D4D8DC-2239-4452-99AD-E350389825AFQ35009587-068B3F39-2CDF-4951-8A39-BCD5DF62CAC9Q35964423-A3EAE392-8683-469D-BD49-23AC5CDCAB10Q36008501-A134BECF-31FB-46EB-87E0-64626CC58030Q36678551-0CB7317C-9220-4D16-9F9A-E119437551ACQ37214956-602FBB3A-E42B-4CFC-B776-0C5EF295760AQ37402798-1DF21E49-6988-4AFF-924C-309DD9B78949Q38156228-E16FAB92-C81D-4E46-909D-6802538EEA05Q45117344-BCA38FF1-C21E-4B50-9F6D-C43CB5F59D89Q54581417-367B07D7-C028-4336-AB66-E92F235C5DAB
P2860
Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between a high-exp ...... giomyolipomas in TSC2 patients
@en
Association between a high-exp ...... iomyolipomas in TSC2 patients.
@nl
type
label
Association between a high-exp ...... giomyolipomas in TSC2 patients
@en
Association between a high-exp ...... iomyolipomas in TSC2 patients.
@nl
prefLabel
Association between a high-exp ...... giomyolipomas in TSC2 patients
@en
Association between a high-exp ...... iomyolipomas in TSC2 patients.
@nl
P2093
P2860
P356
P1476
Association between a high-exp ...... giomyolipomas in TSC2 patients
@en
P2093
Andres Nieto
David Franz
David J Kwiatkowski
Elizabeth A Thiele
John Bissler
Katherine Sims
Penelope Roberts
Sandra L Dabora
P2860
P304
P356
10.1086/342718
P407
P577
2002-08-21T00:00:00Z